Luis‐Emilio García‐Pérez

Adherence to Therapies in Patients with Type 2 Diabetes

Luis‐Emilio García‐Pérez, María Daca-Álvarez, Tatiana Dilla et al. · Diabetes Therapy · 2013 · 717 citations · Full text

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Tali Cukierman‐Yaffe, Hertzel C. Gerstein, Helen M. Colhoun et al. · The Lancet Neurology · 2020 · 262 citations

Rewind Trial, Diabetes Management, Alzheimer's Disease +8

Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial

Bernhard Ludvik, Juan P. Frías, Francisco J. Tinahones et al. · The Lancet Diabetes & Endocrinology · 2018 · 253 citations · Full text

Diabetes Management, Diabetes, Pharmacology +8

Legume consumption is inversely associated with type 2 diabetes incidence in adults: A prospective assessment from the PREDIMED study

Nerea Becerra‐Tomás, Andrés Díaz‐López, Núria Rosique-Esteban et al. · Clinical Nutrition · 2017 · 169 citations

Metabolic Syndrome, Nutrition, Diabetes Epidemiology +8

Effect of once‐weekly dulaglutide on glycated haemoglobin ( <scp>HbA1c</scp> ) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline <scp>HbA1c</scp>

Baptist Gallwitz, Samuel Dagogo‐Jack, Vivian T. Thieu et al. · Diabetes Obesity and Metabolism · 2017 · 86 citations · Full text